NEW YORK, Sept. 30, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Prosensa Holding N.V. ("Prosensa Holding" or the "Company") (NasdaqGS: RNA). The investigation focuses on whether the Company and its executives complied with federal securities laws. The investigation relates to allegations that the Company's Registration Statement and Prospectus issued in connection with its initial public offering on June 28, 2013 were materially false and misleading. Specifically, the investigation focuses on allegations that the Prosensa Holding misrepresented or failed to disclose material facts concerning the efficacy of drisapersen and its prospects for marketing and regulatory approval.
If you are aware of any facts relating to this investigation, or purchased shares of Prosensa Holding, you can assist this investigation by contacting Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein 212-697-6484 firstname.lastname@example.orgSOURCE Bronstein, Gewirtz & Grossman, LLC